GlassScriptPhysician profile
Amanda K Jensen
NPI 1457005613
$3,713.70
in general payments reported to CMS, 2019-2025
17 companies · $803 in 2025
The $803 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $827 · 2023: $929 · 2024: $1,154 · 2025: $803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,707 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,707.24 |
| Education | $178.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,014.35 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $687.22 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $512.40 | 2022-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $390.10 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $363.84 | 2022-2025 | Ilumya |
| Mallinckrodt Hospital Products INC. | $238.82 | 2024-2025 | Acthar |
| Incyte Corporation | $121.78 | 2022-2025 | Opzelura |
| Ucb, INC. | $108.24 | 2024-2025 | Bimzelx |
| Pfizer INC. | $75.89 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $54.52 | 2024-2025 | Sotyktu |
| Almirall LLC | $40.48 | 2022-2023 | Seysara |
| Leo Pharma INC. | $36.75 | 2023-2025 | Adbry |
| Arcutis Biotherapeutics, INC. | $15.68 | 2024 | Zoryve |
| Galderma Laboratories, L.P. | $15.17 | 2025 | Nemluvio |
| Janssen Biotech, INC. | $14.97 | 2025 | Tremfya |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $13.81 | 2023 | Ycanth |
| Mayne Pharma Commercial LLC | $9.68 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Jensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.